Search

Boehringer Ingelheim announces 2018 BVDzero Case Awards

Boehringer Ingelheim announces 2018 BVDzero Case Awards Boehringer Ingelheim will provide a total prize of €15,000 for the top 10 clinical cases entered Applications can be submitted on www.bvdzero.com

Animal Health Collaboration with Novozymes

Boehringer Ingelheim Animal Health and Novozymes today announced a strategic collaboration to develop and commercialize probiotics for global poultry production. Boehringer Ingelheim will market and distribute Novozymes’ FloraMax® probiotic product f

AMR_Action_Fund

Boehringer Ingelheim joins AMR Action Fund to support antibiotic R&D

Boehringer Ingelheim advances SIRP immune-oncology program

Boehringer and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371

World Rabies Day: BI fights rabies misconceptions

Boehringer Ingelheim joins efforts to fight rabies under this year’s theme for World Rabies Day to raise awareness of the disease and its prevention.

Partnership to Develop Urea Cycle Disorders Therapy

Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders

Largest European development center for biotechnology

Boehringer Ingelheim inaugurates largest European development center for biotechnology

Niha Agarwalla

My career challenge at Boehringer Ingelheim by Niha Agarwalla. Read it now!

Boehringer Ingelheim announces appointments Board of Managing Directors

ATM-Ranking-2021

Boehringer Ingelheim climbs two places. New early-stage research projects for disease areas relevant to low-to-middle income countries not reflected.

bix_facilitates_global_partnerships

BI X focuses on partnerships to speed up the development of digital healthcare solutions

Investment of 65 million euro in avian vaccines in France

Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Portes-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian vaccines

Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry

Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being

BI_X_Shanghai

Boehringer Ingelheim opens a second branch of its digital lab in Shanghai

Boehringer Ingelheim acquires a stake in SoundTalks

Boehringer Ingelheim acquires stake in SoundTalks NV, begins pilot programme

Boehringer Ingelheim partners with GNA Biosolutions

Boehringer Ingelheim partners with GNA Biosolutions to develop African swine fever diagnostic test.

2020 European PRRS Research Award sponsorship

2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions

inauguration_biopharmaceutical_production_facility_vienna

The state-of-the-art biopharmaceutical production facility in Vienna is the single largest investment in the company's history.